At different stages of any research project, molecular biologists need to choose—often somewhat arbitrarily, even after careful statistical data analysis—which genes or proteins to …
DW Parsons, S Jones, X Zhang, JCH Lin, RJ Leary… - science, 2008 - science.org
Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes …
S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary… - science, 2008 - science.org
There are currently few therapeutic options for patients with pancreatic cancer, and new insights into the pathogenesis of this lethal disease are urgently needed. Toward this end …
MJ Lee, SY Albert, AK Gardino, AM Heijink, PK Sorger… - Cell, 2012 - cell.com
Crosstalk and complexity within signaling pathways and their perturbation by oncogenes limit component-by-component approaches to understanding human disease. Network …
BB Nankova, R Agarwal, DF MacFabe, EF La Gamma - PLoS One, 2014 - journals.plos.org
Alterations in gut microbiome composition have an emerging role in health and disease including brain function and behavior. Short chain fatty acids (SCFA) like propionic (PPA) …
S Buonamici, J Williams, M Morrissey, A Wang… - Science translational …, 2010 - science.org
The malignant brain cancer medulloblastoma is characterized by mutations in Hedgehog (Hh) signaling pathway genes, which lead to constitutive activation of the G protein …
K Hao, Y Bossé, DC Nickle, PD Paré, DS Postma… - PLoS …, 2012 - journals.plos.org
Genome-wide association studies (GWAS) have identified loci reproducibly associated with pulmonary diseases; however, the molecular mechanism underlying these associations are …
I Gashaw, P Ellinghaus, A Sommer, K Asadullah - Drug discovery today, 2011 - Elsevier
Novel therapeutics in areas with a high unmet medical need are based on innovative drug targets. Although 'biologicals' have enlarged the space of druggable molecules, the number …
GC Terstappen, C Schlüpen, R Raggiaschi… - Nature Reviews Drug …, 2007 - nature.com
Recognition of some of the limitations of target-based drug discovery has recently led to the renaissance of a more holistic approach in which complex biological systems are …